Takara Bio (Germany) Today
| TF2 Stock | EUR 5.40 1.14 26.76% |
PerformanceFair
| Odds Of DistressFair
|
Takara Bio is trading at 5.40 as of the 16th of February 2026. This is a 26.76 percent increase since the beginning of the trading day. The stock's lowest day price was 4.16. Takara Bio has 46 percent odds of going through some form of financial distress in the next two years but had a very fair returns during the last 90 days. The performance scores are derived for the period starting the 18th of November 2025 and ending today, the 16th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Takara Bio Inc., together with its subsidiaries, operates as a biotechnology company in Japan, the United States, China, other Asia, Europe, and internationally. The company was founded in 2002 and is headquartered in Kusatsu, Japan. TAKARA BIO is traded on Frankfurt Stock Exchange in Germany.. The company has 120.42 M outstanding shares. More on Takara Bio
Moving against Takara Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Takara Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Takara Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Takara Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Tsuyoshi Miyamura | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Takara Bio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Takara Bio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsTakara Bio utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Takara Bio's leverage profile, showing how much of Takara Bio's resources are funded through borrowing.
| |||||
Takara Bio (TF2) is traded on Frankfurt Exchange in Germany and employs 1,779 people. Takara Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 702.76 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takara Bio's market, we take the total number of its shares issued and multiply it by Takara Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Takara Bio classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 120.42 M outstanding shares.
Takara Bio has accumulated about 31.49 B in cash with 5.84 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 261.48, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Takara Bio Probability Of Bankruptcy
Ownership AllocationTakara Bio shows a total of 120.42 Million outstanding shares. Takara Bio has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.73 % of Takara Bio outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Takara Ownership Details
Takara Bio Historical Income Statement
Takara Stock Against Markets
Takara Stock Analysis Notes
About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takara Bio recorded a loss per share of 0.29. The entity last dividend was issued on the 30th of March 2026. The firm had 400:1 split on the 29th of March 2011. Takara Bio Inc., together with its subsidiaries, operates as a biotechnology company in Japan, the United States, China, other Asia, Europe, and internationally. The company was founded in 2002 and is headquartered in Kusatsu, Japan. TAKARA BIO is traded on Frankfurt Stock Exchange in Germany. To find out more about Takara Bio contact Koichi Nakao at 81 77 565 6920 or learn more at https://www.takara-bio.com.Takara Bio Quarterly Total Revenue |
|
Takara Bio Investment Alerts
| Takara Bio had very high historical volatility over the last 90 days | |
| About 62.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Takara Bio Swings to Deep Loss, Confirms Forecast and Scraps Dividend - TipRanks |
Takara Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 702.76 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takara Bio's market, we take the total number of its shares issued and multiply it by Takara Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Takara Profitablity
Takara Bio's profitability indicators refer to fundamental financial ratios that showcase Takara Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Takara Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Takara Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Takara Bio's profitability requires more research than a typical breakdown of Takara Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.26) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.26. Management Efficiency
At this time, Takara Bio's Intangible Assets are most likely to increase significantly in the upcoming years. The Takara Bio's current Non Currrent Assets Other is estimated to increase to about 1.8 B, while Total Assets are projected to decrease to roughly 97.1 B. Takara Bio's management efficiency ratios could be used to measure how well Takara Bio manages its routine affairs as well as how well it operates its assets and liabilities.Leadership effectiveness at Takara Bio is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 16th of February 2026, Takara Bio has the Semi Deviation of 2.23, coefficient of variation of 1596.91, and Risk Adjusted Performance of 0.0585. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Takara Bio, as well as the relationship between them. Please validate Takara Bio jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if Takara Bio is priced more or less accurately, providing market reflects its prevalent price of 5.4 per share.Takara Bio Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Takara Bio Tanh Of Price Series is a hyperbolic price transformation function.
Takara Bio Outstanding Bonds
Takara Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Takara Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Takara bonds can be classified according to their maturity, which is the date when Takara Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Takara Bio Predictive Daily Indicators
Takara Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Takara Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Takara Bio Forecast Models
Takara Bio's time-series forecasting models are one of many Takara Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Takara Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Takara Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Takara Bio Corporate Management
Elected by the shareholders, the Takara Bio's board of directors comprises two types of representatives: Takara Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Takara. The board's role is to monitor Takara Bio's management team and ensure that shareholders' interests are well served. Takara Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Takara Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Junichi Mineno | Executive VP | Profile | |
| Katsuhiko Kusakabe | Managing Officer | Profile | |
| Andrew Farmer | Head Development | Profile | |
| Ikuei Nukaya | Managing Headquarters | Profile | |
| Koichi Nakao | Pres CEO | Profile | |
| MS MS | Ex Director | Profile | |
| Mutsumi Sano | Sr Officer | Profile |
Other Information on Investing in Takara Stock
Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.